The World Health Organization announced today the resumption of clinical trials of an antimalarial drug (File)
Geneva:
The World Health Organization said on Wednesday that clinical trials of the drug hydroxychloroquine would resume, having been suspended pending a review of the safety of treatments for coronaviruses.
“Based on the available mortality data … the steering group will contact the main investigators of the trial regarding the resumption of the hydroxychloroquine arm,” said WHO chief Tedros Adhanom Ghebreyesus during a virtual press point.
(With the exception of the title, this story was not edited by GalacticGaming staff and is published from a syndicated feed.)
